Literature DB >> 2436750

Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas.

A Basu, U Murthy, U Rodeck, M Herlyn, L Mattes, M Das.   

Abstract

The epidermal growth factor (EGF) receptor in two colon carcinoma lines and in one vulval carcinoma line tested contains carbohydrate determinants that are recognized by monoclonal antibodies to tumor-associated antigens. These antibodies are directed to sialylated Lea and to difucosylated structures of the Y type. Cell lines which react with these antibodies express these antigens on their surface glycolipids and glycoproteins, including the EGF receptor. These unusual carbohydrates are absent in EGF receptors from normal untransformed cells, and from tumor cells which do not express these specific antigens. Although EGF receptor represents only 0.1-2% of total plasma membrane proteins of antigen-positive carcinomas, it accounts for 20-80% of total protein-associated sialylated Lea/Y type of nonsecreted carbohydrates present in these cells. The results of cell-binding, immunoprecipitation, and Western blot analyses of the antigen-positive carcinomas indicate that sialylated Lea/Y type of antigenicity is intrinsic to the EGF receptors of these cells, and that the antigen is present in receptors from both over-expressing and normal-expressing carcinomas.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436750

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Nuclear translocation of monoclonal antibody directed against cell-surface carbohydrate Y determinant.

Authors:  E M Rakowicz-Szulczynska; Z Steplewski; H Koprowski
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

Review 2.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

3.  Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation.

Authors:  A Basu; M Raghunath; S Bishayee; M Das
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

4.  The relationship between the expression of blood group-related antigens and the cell proliferation of pancreatic carcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.

Authors:  T Kobayashi; E Uchida; K Tamura; N Yamanaka
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 5.  Immunology of gliomas.

Authors:  N de Tribolet
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

6.  Lewis Y promotes growth and adhesion of ovarian carcinoma-derived RMG-I cells by upregulating growth factors.

Authors:  Feifei Li; Bei Lin; Yingying Hao; Yan Li; Juanjuan Liu; Jianping Cong; Liancheng Zhu; Qing Liu; Shulan Zhang
Journal:  Int J Mol Sci       Date:  2010-09-29       Impact factor: 5.923

7.  Invasive breast cancer in Argentine women: association between risk and prognostic factors with antigens of a peptidic and carbohydrate nature.

Authors:  Sandra O Demichelis; Marina T Isla-Larrain; Luciano Cermignani; Cecilio G Alberdi; Amada Segal-Eiras; María Virginia Croce
Journal:  Breast Cancer (Dove Med Press)       Date:  2011-12-20

8.  Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).

Authors:  Marina Isla Larrain; Sandra Demichelis; Marina Crespo; Ezequiel Lacunza; Alberto Barbera; Aldo Cretón; Francisco Terrier; Amada Segal-Eiras; María Virginia Croce
Journal:  J Exp Clin Cancer Res       Date:  2009-08-28

9.  A possible role for metallic ions in the carbohydrate cluster recognition displayed by a Lewis Y specific antibody.

Authors:  William Farrugia; Andrew M Scott; Paul A Ramsland
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

10.  Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.

Authors:  Juanjuan Liu; Bei Lin; Yingying Hao; Yue Qi; Liancheng Zhu; Feifei Li; Dawo Liu; Jianping Cong; Shulan Zhang; Masao Iwamori
Journal:  J Exp Clin Cancer Res       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.